How much cash does Sanara MedTech Inc. generate?

Sanara MedTech Inc. (SMTI) generated $6.3M in operating cash flow over the trailing twelve months.

What is Sanara MedTech Inc.'s free cash flow?

After $2.9M of capital expenditures, Sanara MedTech Inc.'s free cash flow was -$3.8M over the trailing twelve months, up 36.7% year over year.

Where does Sanara MedTech Inc.'s cash flow data come from?

Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Sanara MedTech Inc. SMTI Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Net income	-$33.58M+10.6%	-$37.57M+0.2%	-$37.66M-272%	-$10.13M+13.0%	-$11.64M-17.4%
Depreciation and amortization	$3.41M-13.6%	$3.95M-19.2%	$4.89M-1.3%	$4.95M+0.2%	$4.94M+0.4%
Stock-based compensation	$4.88M-5.4%	$5.15M-0.3%	$5.17M+4.2%	$4.96M+0.5%	$4.94M+11.3%
Impairment charges	——	——	——	——	——
Provision for credit losses	$405.2K-20.4%	$509.23K-40.3%	$852.75K+11.8%	$762.55K+3.3%	$738.48K+18.3%
Change in accounts receivable	——	——	——	——	$3.41M-24.5%
Change in inventories	$415.26K-76.7%	$1.79M+71.6%	$1.04M+79.1%	$581.33K+231%	-$443.97K+69.2%
Change in accounts payable	-$1.22M-249%	$814K—	——	——	——
Change in other assets	——	——	$376.19K-47.1%	$710.95K+296%	$179.56K-65.2%
Other working capital changes	$333.1K-36.6%	$525.37K-23.6%	$687.34K-2.4%	$704.3K-2.3%	$720.84K+31.7%
Net gains (losses) on investments	-$1.27M-33.5%	-$952.47K-38.8%	-$686.29K-59.9%	-$429.1K—	——
Change in operating lease liabilities	-$332.06K+37.0%	-$526.91K+24.4%	-$696.93K-3.7%	-$672.02K+2.0%	-$685.75K-36.4%
Net cash from operating activities	$6.32M-6.9%	$6.79M—	——	——	——
Capital expenditures	$2.95M-36.3%	$4.63M+0.2%	$4.62M+29.5%	$3.57M+91.4%	$1.86M+805%
Proceeds from sale of property, plant and equipment	——	——	——	——	——
Purchases of equity securities	——	$8.26M+39.2%	$5.93M—	——	——
Net cash from investing activities	-$9.84M+34.3%	-$14.97M-18.3%	-$12.66M+18.8%	-$15.59M-33.0%	-$11.73M-77.3%
Proceeds from issuance of debt	——	——	——	——	——
Other financing activities	——	——	——	——	——
Net cash from financing activities	——	——	——	——	$31.21M+68.1%
Net increase (decrease) in cash	——	——	——	——	$18.26M+64.0%
Interest paid	$4.24M+26.6%	$3.35M+9.5%	$3.06M+20.1%	$2.55M+27.3%	$2M+26.6%
Income taxes paid	——	——	——	——	$83.42K+106%
Accretion Of Finance Liabilities	$131.66K-11.1%	$148.18K-9.8%	$164.36K-8.8%	$180.21K-7.9%	$195.73K-7.2%
Accrued Interest Income Expense	——	——	——	——	——
Amortization And Writeoff Of Debt Issuance Costs	$294.17K+5.1%	$279.91K+5.4%	$265.64K+10.0%	$241.44K-9.1%	$265.7K+26.8%
Asset write-downs	——	——	——	——	——
Backend Fee	$786.18K+0.8%	$780.31K+8.8%	$717.3K+5.0%	$683.08K—	——
Equity in earnings (losses) of equity method investees	-$1.27M-33.5%	-$952.47K-38.8%	-$686.29K-59.9%	-$429.1K—	——
Increase Decrease In Accounts Payable Related Party	-$958+83.8%	-$5.91K+95.2%	-$123.27K-9.0%	-$113.13K-150%	-$45.31K+3.4%
Increase Decrease In Accounts Receivable Related Parties	——	-$40.57K—	——	——	——
Increase Decrease In Accrued Bonuses And Commissions	$1.57M-26.0%	$2.13M-51.7%	$4.4M+26.3%	$3.48M+164%	$1.32M-57.5%
Increase Decrease In Accrued Royalties And Expenses	——	——	$728.05K—	——	——
Operating lease liabilities	-$332.06K+37.0%	-$526.91K+24.4%	-$696.93K-3.7%	-$672.02K+2.0%	-$685.75K-36.4%
Increase (Decrease) in Prepaid Expense and Other Assets	——	——	$376.19K-47.1%	$710.95K+296%	$179.56K-65.2%
Inventory write-downs	$445.57K-23.4%	$582.05K-11.1%	$655.07K+3.3%	$634.14K+1.3%	$625.8K+19.9%
Payment-in-kind interest	——	$2.2M+9.5%	$2.01M+20.1%	$1.67M—	——
Accounts Receivable, Credit Loss Expense (Reversal)	$405.2K-20.4%	$509.23K-40.3%	$852.75K+11.8%	$762.55K+3.3%	$738.48K+18.3%
Payments to Acquire Equity Method Investments	——	$8.26M+39.2%	$5.93M—	——	——
Proceeds from disposals of property, plant and equipment	——	——	——	——	——
Cash Payment Of Finance And Earnout Liabilities	$937K0.0%	$937K-53.7%	$2.02M0.0%	$2.02M0.0%	$2.02M0.0%
Other, net	——	——	——	——	——
Proceeds from issuance of commercial paper and other short-term borrowings	——	——	——	——	——
Conversion Of Note Receivable Into Equity Method Investment	——	——	——	——	——
Increase Decrease In Operating Lease Liability	-$332.06K+37.0%	-$526.91K+24.4%	-$696.93K-3.7%	-$672.02K+2.0%	-$685.75K-36.4%
Nonmonetary Exchange To Acquire Intangible Assets	——	——	——	——	——
Income Taxes Paid, Net	——	——	——	——	$83.42K+106%
Free cash flow	——	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Sanara MedTech Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Sanara MedTech Inc. generate?: Sanara MedTech Inc. (SMTI) generated $6.3M in operating cash flow over the trailing twelve months.
What is Sanara MedTech Inc.'s free cash flow?: After $2.9M of capital expenditures, Sanara MedTech Inc.'s free cash flow was -$3.8M over the trailing twelve months, up 36.7% year over year.
Where does Sanara MedTech Inc.'s cash flow data come from?: Every line is extracted from Sanara MedTech Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.